Corlanor (Ivabradine)

Ivabradine is a medicine used to lower heart rate. It helps people with certain heart conditions, like angina or heart failure, by slowing down how fast their heart beats. It's often used when other heart medicines can't be taken.

Brand names:Corlanor, Procoralan
Medication

What people taking Corlanor (Ivabradine) report

Every report comes from a Lived member, sent anonymously.

Have you tried Corlanor (Ivabradine) for Heart Failure?

NameHow it went

About Corlanor (Ivabradine)

What It's For

Ivabradine, sold in the US as Corlanor and also available as a generic, is a prescription heart medicine that slows the heart rate. In adults, it is used for chronic heart failure in which the heart's main pumping chamber squeezes out 35% or less of the blood it holds with each beat, a measurement called the ejection fraction. It is meant for people whose heart failure is stable, whose heart is in its normal rhythm (sinus rhythm) and whose resting heart rate stays at 70 beats per minute or higher even though they take the highest beta-blocker dose they can tolerate, or who cannot take a beta-blocker at all. It is an add-on rather than a replacement for standard heart failure treatment. In the large trial that led to its approval, ivabradine lowered the chance of being hospitalized for worsening heart failure, but it did not reduce deaths from heart disease. In children 6 months and older, Corlanor is approved for stable heart failure caused by dilated cardiomyopathy, a condition in which the heart muscle is enlarged and weakened, when the heart rate is elevated. In Europe, ivabradine is sold as Procoralan and is also approved to relieve angina (chest pain from narrowed heart arteries). That is not a US-approved use, and a large trial in people with stable coronary artery disease but no heart failure found that adding ivabradine did not prevent heart attacks or cardiac deaths.

How It Works

Each heartbeat starts in the sinus node, a small cluster of cells in the upper heart that acts as a natural pacemaker. These cells set the pace through a slow inward electrical current that gradually triggers the next beat. Ivabradine blocks the channels that carry this current, so the next beat arrives a little later and the heart rate falls. Unlike beta-blockers or some calcium channel blockers, ivabradine slows the heart without weakening the force of each contraction or lowering blood pressure much. A slower rate gives a weakened heart more time to fill between beats and reduces how hard it has to work. Because the drug acts on the sinus node, it only helps when that node is setting the rhythm. It does not slow the heart in atrial fibrillation, an irregular rhythm that bypasses the sinus node, and it has little role when a pacemaker sets the rate.

Dosage & Administration

Ivabradine is taken twice a day with food. Adults usually start at 5 mg twice daily, or 2.5 mg twice daily if they have a history of heart conduction problems or are especially vulnerable to a slow heart rate. After about two weeks, the prescriber checks the resting heart rate and adjusts the dose, aiming for 50 to 60 beats per minute. The dose goes up if the rate is still above 60 and down if it falls below 50 or causes symptoms, up to a maximum of 7.5 mg twice daily. Children take a dose based on body weight. Those under 40 kg use the oral solution, which comes in single-use ampules: the contents are emptied into a medicine cup, the dose is measured with an oral syringe, and any leftover liquid is thrown away. A caregiver should give the dose rather than the child. If a dose is missed or spit out, do not give an extra dose; give the next one at the usual time. Adults who cannot swallow tablets can also use the solution.

Side Effects

The most common effect is a heart rate that drops further than intended. In the main adult trial, about 1 in 10 people on ivabradine developed a slow heart rate. Dizziness, unusual tiredness or lightheadedness can be signs of this and should be reported to the prescriber promptly, since the dose may need to be lowered or stopped. Fainting needs urgent medical attention the same day. Some people notice phosphenes: brief flashes or areas of extra brightness in part of their vision, halos or a kaleidoscope-like effect, usually triggered by sudden changes in light. These typically begin within the first two months, are mild to moderate, and often fade with continued treatment. Because they can be distracting, take care when driving, particularly at night when headlights cause sudden changes in brightness. Ivabradine also raises the risk of atrial fibrillation. A pounding, racing or irregular heartbeat, chest pressure or shortness of breath that gets worse should be reported promptly, because the medicine is stopped if atrial fibrillation develops. Blood pressure can also rise in some people, so it is checked during follow-up.

Interactions & Warnings

Ivabradine is broken down in the liver by an enzyme called CYP3A4, so medicines that block or speed up this enzyme change how much of the drug is in the blood. It must not be combined with strong blockers of this enzyme, such as the antifungal itraconazole, the antibiotic clarithromycin, some HIV medicines and the antidepressant nefazodone, because levels can rise high enough to slow the heart dangerously. Diltiazem and verapamil (calcium channel blockers used for blood pressure and heart rhythm) should also be avoided, as should grapefruit juice. The herbal supplement St. John's wort, the antibiotic rifampin (used mainly for tuberculosis) and some seizure medicines should also be avoided, because they can make ivabradine less effective. Other heart-slowing medicines, such as beta-blockers, digoxin and amiodarone, are often used alongside it but call for closer heart rate checks. Ivabradine is not used during acutely worsening heart failure, with significantly low blood pressure or an already very slow heart rate, with certain problems in the heart's electrical signaling, such as sick sinus syndrome or complete heart block, unless a working pacemaker is in place, when the heart rate depends entirely on a pacemaker, or with severe liver disease. In animal studies, ivabradine caused heart defects in developing offspring. People who could become pregnant should use effective birth control while taking it and contact the prescriber right away about a known or suspected pregnancy. Breastfeeding is not recommended during treatment.

What to Expect

The heart rate begins to fall soon after starting, but finding the right dose takes a few visits. Expect heart rate checks about every two weeks at first, and an occasional heart rhythm tracing (ECG) to look for atrial fibrillation. Keeping a log of home heart rate readings can help the care team. Ivabradine does not usually make people feel dramatically different day to day. Its purpose is to lower the chance of a hospital stay for worsening heart failure over months and years, so it is typically continued long term alongside other heart failure medicines. Because ivabradine is added only after beta-blockers and other standard treatments, the overall plan matters more than any single drug, and the prescriber may revisit it if the heart rhythm changes, a pacemaker is placed or other medicines are adjusted.

Questions to Ask Your Doctor

  1. 1.Why is ivabradine being added for me, and how does it fit with my beta-blocker and other heart failure medicines?
  2. 2.What heart rate are we aiming for, and should I be checking my pulse at home?
  3. 3.Are any of my current prescriptions, supplements or foods likely to interact with ivabradine?
  4. 4.What should I do if I notice visual flashes, dizziness or a racing or irregular heartbeat?
  5. 5.If I might become pregnant, what birth control and alternative treatments should we discuss?

Last reviewed • Oct 2026

Educational content, not medical advice.